Peter Marks
- Immunology and Allergy top 2%
- Hematology top 2%
- Acute Myeloid Leukemia Research 7
- Iron Metabolism and Disorders 7
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 10
- Genetics top 2%
- Hemoglobinopathies and Related Disorders 11
- Oncology top 5%
- CAR-T cell therapy research 8
-
- SARS-CoV-2 and COVID-19 Research 8
-
- Biomedical Ethics and Regulation 6
-
- Blood donation and transfusion practices 6
- Co-authors
- Robert M. CaliffFrederick R. MaxfieldSteven A. AndersonJanet WoodcockJeffrey ShurenThomas P. GrossLisa M. LaVangeRachel E. Sherman
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter Marks
96 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Immunology and Allergy 325
- Hematology 516
- Internal Medicine 167
- Genetics 456
- Oncology 783
Countries citing papers authored by Peter Marks
This map shows the geographic impact of Peter Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Marks more than expected).
Fields of papers citing papers by Peter Marks
This network shows the impact of papers produced by Peter Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Marks. The network helps show where Peter Marks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapybreakdown → | 2024 | 150 |
| 5 | 2024 | 16 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 32 | |
| 9 | 2021 | 182 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 14 | |
| 12 | 2016 | 15 | |
| 13 | 2010 | 19 | |
| 14 | 2009 | 8 | |
| 15 | 2004 | 37 | |
| 16 | 2003 | 255 | |
| 17 | 1999 | 309 | |
| 18 | 1999 | 2 | |
| 19 | 1996 | 25 | |
| 20 | 1974 | 19 |
About Peter Marks
Peter Marks is a scholar working on Internal Medicine, Hematology and Genetics, having authored 103 papers that have together received 5.0k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers), CAR-T cell therapy research (8 papers), Acute Myeloid Leukemia Research (7 papers), Iron Metabolism and Disorders (7 papers), Biomedical Ethics and Regulation (6 papers) and Blood donation and transfusion practices (6 papers). The work is most often cited by research in Immunology and Allergy (325 citations), Hematology (516 citations) and Internal Medicine (167 citations). Peter Marks has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert M. Califf, Frederick R. Maxfield, Steven A. Anderson, Janet Woodcock, Jeffrey Shuren, Thomas P. Gross, Lisa M. LaVange, Rachel E. Sherman, Danica Marinac‐Dabic and Robert Temple. Their work appears in journals such as Blood, New England Journal of Medicine, Transfusion, JAMA and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.